CYTOKINE MAP

Brand	Owner	Address	Description
CYTOKINEMAP	RULES-BASED MEDICINE, INC.	3300 Duval Road, Suite 110 Austin TX 78759	CYTOKINE MAP;Laboratory and medical kits for use in research in the fields of immunological and biological research, pharmaceutical research, pre-clinical screening, and clinical trial research consisting primarily of antibodies, protein standard solutions, buffers, assay control reagents, and detection reagents;Biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs and the environment;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention provides a cytokine-binding domain or portion thereof which binds to at least one cytokine and is capable of transducing a cytokine signal through a single cytokine receptor, said domain comprising a portion of the B'-C' loop of domain 4 of a ?c chain or analogous structure of a cytokine receptor. In another aspect of the invention there is provided a method of identifying a compound having cytokine agonist or antagonist activity, said method including subjecting a potential cytokine agonist and/or cytokine antagonist compound to a cytokine binding domain or portion thereof wherein said domain binds to at least one cytokine and is capable of transducing a cytokine signal through a single cytokine receptor, said domain comprising a portion of the B'-C' loop of domain 4 of a ?c chain or analogous structure of the cytokine receptor; and determining the presence of an agonist or antagonist response of the compound on the activity of a cytokine. In a preferred aspect there is provided a method fo identifying a GM-CSF, IL-3 and IL-5 agonist or antagonist, said method including: subjecting a potential agonist or antagonist to a GM-CSF, IL-3 and IL-5 binding domain or portion thereof wherein said domain binds to at least one of the cytokines and is capable of transducing a cytokine signal through a single cytokine receptor, said domain comprising a portion of the B'-C' loop of domain 4 of a ?c chain or analogous structure of the cytokine receptor; and determining the presence of a agonist or antagonist response from the compound on the activity of GM-CSF, IL-3 and IL-5.